← Eichor
Condition: Hypopituitarism Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Hypopituitarism

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Neuropsychological Assessment of Children and Adolescents With Turner Syndrome
Phase N/A · 3 location(s) · University Hospital, Angers · NCT03812913Growth Hormone Replacement Therapy in Veterans With Mild Traumatic Brain Injury (mTBI) and Adult Growth Hormone Deficien
Phase 3 · 16 location(s) · VA Office of Research and Development · NCT04867317Pituitary Function After Recovery From Septic Shock Among ICU Survivors
Phase N/A · 2 location(s) · Sanjay Gandhi Postgraduate Institute of Medical Sciences · NCT05990491Effects of Intranasal Oxytocin in Patients With Arginine-vasopressin Deficiency
Phase 1 · 1 location(s) · Elizabeth Austen Lawson · NCT04789148Identifying Oxytocin Deficiency in Pediatric Patients With Pituitary Disease
EARLY_Phase 1 · 1 location(s) · Massachusetts General Hospital · NCT07568509Safety, Pharmacokinetic (PK) Profile and Efficacy of Inpegsomatropin Injection in Adults With Growth Hormone Deficiency
Phase 2 · 6 location(s) · Xiamen Amoytop Biotech Co., Ltd. · NCT07551804REMS25: Study on the Use of REMS Technology in Diseases Commonly Associated With Reduced Bone Mineral Density (BMD)
NA · 1 location(s) · Meyer Children's Hospital IRCCS · NCT07412782A Post-Authorisation Safety Study (PASS) of Patients Treated With Lonapegsomatropin
Phase N/A · 27 location(s) · Ascendis Pharma Endocrinology Division A/S · NCT05775523Phase 3 Study of LUM-201 in Children With Growth Hormone Deficiency
Phase 3 · 43 location(s) · Lumos Pharma · NCT06948214Sleep Disorders in Hypothalamic and Pituitary Damage
Phase N/A · 1 location(s) · Fundació Institut de Recerca de l'Hospital de la Santa Creu · NCT07143266Growth Hormone Replacement in Veterans With GWI and AGHD (GWIT)
Phase 2 · 2 location(s) · Baylor College of Medicine · NCT05355272Long-term Safety and Effectiveness of Growtropin®-II Treatment in Children With Short Stature
Phase N/A · 1 location(s) · Dong-A ST Co., Ltd. · NCT04798690Long-term Safety and Effectiveness of Growth Hormone With GHD, TS, CRF, SGA , ISS and PWS in Children
Phase N/A · 1 location(s) · LG Chem · NCT01604395GB06 Phase III Trial for Pediatric Growth Hormone Deficiency
Phase 3 · 1 location(s) · Kexing Biopharm Co., Ltd. · NCT07553351A Study to Learn About Somatrogon in Patients With Pediatric Growth Hormone Deficiency (p GHD) in India.
Phase N/A · 4 location(s) · Pfizer · NCT06587035Growth Hormone Replacement Therapy for Retried Professional Football Players
Phase 2 · 1 location(s) · Center for Neurological Studies · NCT04121780A Clinical Study of GenSci134 in Healthy Adults and Adult Growth Hormone Deficiency(AGHD)
Phase 1 · 1 location(s) · Changchun GeneScience Pharmaceutical Co., Ltd. · NCT07016802GROWing Up With Rare GENEtic Syndromes
Phase N/A · 1 location(s) · dr. Laura C. G. de Graaff-Herder · NCT04463316Chromosome 18 Clinical Research Center
Phase N/A · 2 location(s) · The University of Texas Health Science Center at San Antonio · NCT00227253Evaluation of the Propensity of Patients Under rhGH to Envision a Modification of Their Treatment Regimen Toward LAGH
NA · 1 location(s) · Cliniques universitaires Saint-Luc- Université Catholique de · NCT06542809Effects of GH and Lirglutide on AgRP
Phase 4 · 1 location(s) · Columbia University · NCT05681299A US Non-interventional, Effectiveness and Safety Study of Patients Treated With SKYTROFA
Phase N/A · 27 location(s) · Ascendis Pharma Endocrinology Division A/S · NCT05820672
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.